Forecast: Measles Immunisation in Sweden

The measles immunisation rate in Sweden has shown a stable trend with minor fluctuations between 97% and 98% from 2013 to 2021. In 2022, a notable decline to 92.5% occurred, but the rate rebounded to 96.3% in 2023. Variations over the last two years include a significant drop of 4.64% in 2022, followed by an increase of 4.11% in 2023. From 2021 to 2023, the rate showed a slight negative compound annual growth rate (CAGR) of -0.14%. Forecasts from 2024 to 2028 indicate a stagnation at 96.3%, reflecting a zero growth trend in the future.

Future trends to watch for include potential impacts of public health policies, vaccine hesitancy, and possible outbreaks of measles which could influence immunisation rates. Monitoring these variables will be crucial for maintaining or improving immunisation coverage.

Latest reports

 US Vaccine Market Report- Q1 2025

US Vaccine Market Report- Q1 2025

The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...

 China Vaccine Market Report- Q1 2025

China Vaccine Market Report- Q1 2025

The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...

 Japan Vaccine Market Report- Q4 2024

Japan Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...

 Germany Vaccine Market Report- Q4 2024

Germany Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...

 India Vaccine Market Report- Q4 2024

India Vaccine Market Report- Q4 2024

The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...

 UK Vaccine Market Report- Q4 2024

UK Vaccine Market Report- Q4 2024

The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...

 France Vaccine Market Report- Q4 2024

France Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...

 Canada Vaccine Market Report- Q4 2024

Canada Vaccine Market Report- Q4 2024

The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...

 Brazil Vaccine Market Report- Q4 2024

Brazil Vaccine Market Report- Q4 2024

The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...

 Italy Vaccine Market Report- Q4 2024

Italy Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...

Top Countries about mRNA Vaccine